Latest Insider Transactions at Exelixis, Inc. (EXEL)
This section provides a real-time view of insider transactions for Exelixis, Inc. (EXEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EXELIXIS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EXELIXIS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2025
|
Jack L Wyszomierski Director |
SELL
Open market or private sale
|
Direct |
8,768
-2.4%
|
$324,416
$37.8 P/Share
|
|
Feb 28
2025
|
Jack L Wyszomierski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,874
+4.16%
|
$317,480
$20.5 P/Share
|
|
Feb 28
2025
|
Julie Smith Director |
SELL
Open market or private sale
|
Direct |
19,294
-64.16%
|
$713,878
$37.62 P/Share
|
|
Feb 28
2025
|
Julie Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,294
+39.08%
|
$366,586
$19.77 P/Share
|
|
Feb 27
2025
|
Julie Smith Director |
SELL
Open market or private sale
|
Direct |
54,514
-83.49%
|
$2,071,532
$38.13 P/Share
|
|
Feb 27
2025
|
Julie Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
54,514
+34.48%
|
$1,090,280
$20.14 P/Share
|
|
Feb 26
2025
|
Amy C. Peterson EVP Prod Dev & Med Aff & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
52,192
+13.07%
|
-
|
|
Feb 26
2025
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
52,192
+8.03%
|
-
|
|
Feb 26
2025
|
Patrick J. Haley EVP, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
47,718
+11.97%
|
-
|
|
Feb 26
2025
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Grant, award, or other acquisition
|
Direct |
49,209
+8.06%
|
-
|
|
Feb 26
2025
|
Michael Morrissey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
184,909
+15.18%
|
-
|
|
Feb 26
2025
|
Christopher J. Senner EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
59,648
+6.64%
|
-
|
|
Feb 25
2025
|
Bob Oliver Director |
SELL
Open market or private sale
|
Direct |
18,647
-35.75%
|
$689,939
$37.25 P/Share
|
|
Feb 25
2025
|
Bob Oliver Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,147
+22.5%
|
$287,793
$19.28 P/Share
|
|
Feb 24
2025
|
Christopher J. Senner EVP and CFO |
SELL
Open market or private sale
|
Direct |
29,314
-3.62%
|
$1,055,304
$36.14 P/Share
|
|
Feb 24
2025
|
Christopher J. Senner EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,314
+3.5%
|
$527,652
$18.8 P/Share
|
|
Feb 24
2025
|
Michael Morrissey President and CEO |
BUY
Bona fide gift
|
Indirect |
177,985
+9.16%
|
-
|
|
Feb 24
2025
|
Michael Morrissey President and CEO |
SELL
Bona fide gift
|
Direct |
177,985
-17.34%
|
-
|
|
Feb 24
2025
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Open market or private sale
|
Direct |
26,987
-5.01%
|
$971,532
$36.75 P/Share
|
|
Feb 24
2025
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
52,636
-14.79%
|
$1,894,896
$36.98 P/Share
|
|
Feb 15
2025
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
63,570
-5.83%
|
$2,224,950
$35.0 P/Share
|
|
Feb 15
2025
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
28,748
-2.56%
|
$1,006,180
$35.0 P/Share
|
|
Feb 15
2025
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
18,906
-5.04%
|
$661,710
$35.0 P/Share
|
|
Feb 15
2025
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
18,134
-3.22%
|
$634,690
$35.0 P/Share
|
|
Feb 15
2025
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,591
-2.69%
|
$755,685
$35.0 P/Share
|
|
Feb 14
2025
|
Sue Gail Eckhardt Director |
SELL
Open market or private sale
|
Direct |
11,568
-14.81%
|
$404,880
$35.03 P/Share
|
|
Feb 14
2025
|
Sue Gail Eckhardt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,712
+15.52%
|
$177,376
$23.24 P/Share
|
|
Feb 14
2025
|
Maria C Freire Director |
SELL
Open market or private sale
|
Direct |
44,114
-32.65%
|
$1,499,876
$34.94 P/Share
|
|
Feb 14
2025
|
Maria C Freire Director |
BUY
Exercise of conversion of derivative security
|
Direct |
44,114
+15.11%
|
$926,394
$21.3 P/Share
|
|
Feb 14
2025
|
George Poste Director |
SELL
Open market or private sale
|
Direct |
15,874
-8.59%
|
$539,716
$34.74 P/Share
|
|
Feb 14
2025
|
George Poste Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,874
+7.91%
|
$317,480
$20.5 P/Share
|
|
Feb 14
2025
|
Mary C Beckerle Director |
SELL
Open market or private sale
|
Direct |
12,210
-15.43%
|
$415,140
$34.89 P/Share
|
|
Feb 14
2025
|
Mary C Beckerle Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,354
+16.39%
|
$192,142
$23.24 P/Share
|
|
Jan 16
2025
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
27,563
-6.85%
|
$1,019,831
$37.27 P/Share
|
|
Jan 16
2025
|
Patrick J. Haley EVP, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
123,750
+23.52%
|
-
|
|
Jan 16
2025
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
22,570
-3.82%
|
$835,090
$37.27 P/Share
|
|
Jan 16
2025
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Grant, award, or other acquisition
|
Direct |
104,106
+14.99%
|
-
|
|
Jan 16
2025
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
26,289
-4.46%
|
$972,693
$37.27 P/Share
|
|
Jan 16
2025
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
118,780
+16.76%
|
-
|
|
Jan 16
2025
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
35,949
-4.29%
|
$1,330,113
$37.27 P/Share
|
|
Jan 16
2025
|
Christopher J. Senner EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
132,973
+13.71%
|
-
|
|
Jan 16
2025
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
120,244
-9.94%
|
$4,449,028
$37.27 P/Share
|
|
Jan 16
2025
|
Michael Morrissey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
473,226
+28.11%
|
-
|
|
Dec 20
2024
|
Michael Morrissey President and CEO |
BUY
Bona fide gift
|
Indirect |
179,788
+10.18%
|
-
|
|
Dec 20
2024
|
Michael Morrissey President and CEO |
SELL
Bona fide gift
|
Direct |
179,788
-19.61%
|
-
|
|
Nov 29
2024
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Bona fide gift
|
Direct |
15,000
-3.09%
|
-
|
|
Nov 29
2024
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
60,000
-10.99%
|
$2,160,000
$36.67 P/Share
|
|
Nov 27
2024
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
98,908
-15.34%
|
$3,461,780
$35.93 P/Share
|
|
Nov 27
2024
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
129,314
+16.7%
|
$2,327,652
$18.8 P/Share
|
|
Nov 22
2024
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
10,000
-3.46%
|
$350,000
$35.27 P/Share
|